Report Detail

Pharma & Healthcare Global Ophthalmic Therapeutics/Drug Market Research Report 2018

  • RnM1429295
  • |
  • 13 July, 2018
  • |
  • Global
  • |
  • 112 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Ophthalmic Therapeutics/Drug Market Research Report 2018

Table of Contents

    Global Ophthalmic Therapeutics/Drug Market Research Report 2018

      1 Ophthalmic Therapeutics/Drug Market Overview

      • 1.1 Product Overview and Scope of Ophthalmic Therapeutics/Drug
      • 1.2 Ophthalmic Therapeutics/Drug Segment by Type (Product Category)
        • 1.2.1 Global Ophthalmic Therapeutics/Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
        • 1.2.2 Global Ophthalmic Therapeutics/Drug Production Market Share by Type (Product Category) in 2017
        • 1.2.3 Anti-allergy
        • 1.2.4 Anti-VEGF Agents
        • 1.2.5 Anti-inflammatory
        • 1.2.6 Anti-glaucoma
        • 1.2.7 Others
      • 1.3 Global Ophthalmic Therapeutics/Drug Segment by Application
        • 1.3.1 Ophthalmic Therapeutics/Drug Consumption (Sales) Comparison by Application (2013-2025)
        • 1.3.2 Dry Eye
        • 1.3.3 Allergies
        • 1.3.4 Glaucoma
        • 1.3.5 Infection
        • 1.3.6 Retinal Disorders
        • 1.3.7 Uveitis
        • 1.3.8 Others
      • 1.4 Global Ophthalmic Therapeutics/Drug Market by Region (2013-2025)
        • 1.4.1 Global Ophthalmic Therapeutics/Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
        • 1.4.2 North America Status and Prospect (2013-2025)
        • 1.4.3 Europe Status and Prospect (2013-2025)
        • 1.4.4 China Status and Prospect (2013-2025)
        • 1.4.5 Japan Status and Prospect (2013-2025)
        • 1.4.6 Southeast Asia Status and Prospect (2013-2025)
        • 1.4.7 India Status and Prospect (2013-2025)
      • 1.5 Global Market Size (Value) of Ophthalmic Therapeutics/Drug (2013-2025)
        • 1.5.1 Global Ophthalmic Therapeutics/Drug Revenue Status and Outlook (2013-2025)
        • 1.5.2 Global Ophthalmic Therapeutics/Drug Capacity, Production Status and Outlook (2013-2025)

      2 Global Ophthalmic Therapeutics/Drug Market Competition by Manufacturers

      • 2.1 Global Ophthalmic Therapeutics/Drug Capacity, Production and Share by Manufacturers (2013-2018)
        • 2.1.1 Global Ophthalmic Therapeutics/Drug Capacity and Share by Manufacturers (2013-2018)
        • 2.1.2 Global Ophthalmic Therapeutics/Drug Production and Share by Manufacturers (2013-2018)
      • 2.2 Global Ophthalmic Therapeutics/Drug Revenue and Share by Manufacturers (2013-2018)
      • 2.3 Global Ophthalmic Therapeutics/Drug Average Price by Manufacturers (2013-2018)
      • 2.4 Manufacturers Ophthalmic Therapeutics/Drug Manufacturing Base Distribution, Sales Area and Product Type
      • 2.5 Ophthalmic Therapeutics/Drug Market Competitive Situation and Trends
        • 2.5.1 Ophthalmic Therapeutics/Drug Market Concentration Rate
        • 2.5.2 Ophthalmic Therapeutics/Drug Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Ophthalmic Therapeutics/Drug Capacity, Production, Revenue (Value) by Region (2013-2018)

      • 3.1 Global Ophthalmic Therapeutics/Drug Capacity and Market Share by Region (2013-2018)
      • 3.2 Global Ophthalmic Therapeutics/Drug Production and Market Share by Region (2013-2018)
      • 3.3 Global Ophthalmic Therapeutics/Drug Revenue (Value) and Market Share by Region (2013-2018)
      • 3.4 Global Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.5 North America Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.6 Europe Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.7 China Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.8 Japan Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.9 Southeast Asia Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
      • 3.10 India Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

      4 Global Ophthalmic Therapeutics/Drug Supply (Production), Consumption, Export, Import by Region (2013-2018)

      • 4.1 Global Ophthalmic Therapeutics/Drug Consumption by Region (2013-2018)
      • 4.2 North America Ophthalmic Therapeutics/Drug Production, Consumption, Export, Import (2013-2018)
      • 4.3 Europe Ophthalmic Therapeutics/Drug Production, Consumption, Export, Import (2013-2018)
      • 4.4 China Ophthalmic Therapeutics/Drug Production, Consumption, Export, Import (2013-2018)
      • 4.5 Japan Ophthalmic Therapeutics/Drug Production, Consumption, Export, Import (2013-2018)
      • 4.6 Southeast Asia Ophthalmic Therapeutics/Drug Production, Consumption, Export, Import (2013-2018)
      • 4.7 India Ophthalmic Therapeutics/Drug Production, Consumption, Export, Import (2013-2018)

      5 Global Ophthalmic Therapeutics/Drug Production, Revenue (Value), Price Trend by Type

      • 5.1 Global Ophthalmic Therapeutics/Drug Production and Market Share by Type (2013-2018)
      • 5.2 Global Ophthalmic Therapeutics/Drug Revenue and Market Share by Type (2013-2018)
      • 5.3 Global Ophthalmic Therapeutics/Drug Price by Type (2013-2018)
      • 5.4 Global Ophthalmic Therapeutics/Drug Production Growth by Type (2013-2018)

      6 Global Ophthalmic Therapeutics/Drug Market Analysis by Application

      • 6.1 Global Ophthalmic Therapeutics/Drug Consumption and Market Share by Application (2013-2018)
      • 6.2 Global Ophthalmic Therapeutics/Drug Consumption Growth Rate by Application (2013-2018)
      • 6.3 Market Drivers and Opportunities
        • 6.3.1 Potential Applications
        • 6.3.2 Emerging Markets/Countries

      7 Global Ophthalmic Therapeutics/Drug Manufacturers Profiles/Analysis

      • 7.1 Alcon
        • 7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.1.2 Ophthalmic Therapeutics/Drug Product Category, Application and Specification
          • 7.1.2.1 Product A
          • 7.1.2.2 Product B
        • 7.1.3 Alcon Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.1.4 Main Business/Business Overview
      • 7.2 Johnson and Johnson Vision Care, Inc.
        • 7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.2.2 Ophthalmic Therapeutics/Drug Product Category, Application and Specification
          • 7.2.2.1 Product A
          • 7.2.2.2 Product B
        • 7.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.2.4 Main Business/Business Overview
      • 7.3 Bausch & Lomb Incorporated
        • 7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.3.2 Ophthalmic Therapeutics/Drug Product Category, Application and Specification
          • 7.3.2.1 Product A
          • 7.3.2.2 Product B
        • 7.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.3.4 Main Business/Business Overview
      • 7.4 Novartis AG
        • 7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.4.2 Ophthalmic Therapeutics/Drug Product Category, Application and Specification
          • 7.4.2.1 Product A
          • 7.4.2.2 Product B
        • 7.4.3 Novartis AG Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.4.4 Main Business/Business Overview
      • 7.5 Merck Sharp & Dohme Corp.
        • 7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.5.2 Ophthalmic Therapeutics/Drug Product Category, Application and Specification
          • 7.5.2.1 Product A
          • 7.5.2.2 Product B
        • 7.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
        • 7.5.4 Main Business/Business Overview
      • 7.6 Regeneron Pharmaceuticals Inc.
        • 7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.6.2 Ophthalmic Therapeutics/Drug Product Category, Application and Specification
          • 7.6.2.1 Product A
          • 7.6.2.2 Product B
        • 7.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.6.4 Main Business/Business Overview
      • 7.7 Allergan
        • 7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.7.2 Ophthalmic Therapeutics/Drug Product Category, Application and Specification
          • 7.7.2.1 Product A
          • 7.7.2.2 Product B
        • 7.7.3 Allergan Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.7.4 Main Business/Business Overview
      • 7.8 Pfizer Inc.
        • 7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.8.2 Ophthalmic Therapeutics/Drug Product Category, Application and Specification
          • 7.8.2.1 Product A
          • 7.8.2.2 Product B
        • 7.8.3 Pfizer Inc. Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.8.4 Main Business/Business Overview
      • 7.9 Valeant
        • 7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.9.2 Ophthalmic Therapeutics/Drug Product Category, Application and Specification
          • 7.9.2.1 Product A
          • 7.9.2.2 Product B
        • 7.9.3 Valeant Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
        • 7.9.4 Main Business/Business Overview
      • 7.10 Bayer AG
        • 7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        • 7.10.2 Ophthalmic Therapeutics/Drug Product Category, Application and Specification
          • 7.10.2.1 Product A
          • 7.10.2.2 Product B
        • 7.10.3 Bayer AG Ophthalmic Therapeutics/Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2020)
        • 7.10.4 Main Business/Business Overview
      • 7.11 Santen Pharmaceuticals Co. Ltd
      • 7.12 Genentech, Inc.

      8 Ophthalmic Therapeutics/Drug Manufacturing Cost Analysis

      • 8.1 Ophthalmic Therapeutics/Drug Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
        • 8.1.4 Market Concentration Rate of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
        • 8.2.1 Raw Materials
        • 8.2.2 Labor Cost
        • 8.2.3 Manufacturing Expenses
      • 8.3 Manufacturing Process Analysis of Ophthalmic Therapeutics/Drug

      9 Industrial Chain, Sourcing Strategy and Downstream Buyers

      • 9.1 Ophthalmic Therapeutics/Drug Industrial Chain Analysis
      • 9.2 Upstream Raw Materials Sourcing
      • 9.3 Raw Materials Sources of Ophthalmic Therapeutics/Drug Major Manufacturers in 2017
      • 9.4 Downstream Buyers

      10 Marketing Strategy Analysis, Distributors/Traders

      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
        • 10.1.3 Marketing Channel Development Trend
      • 10.2 Market Positioning
        • 10.2.1 Pricing Strategy
        • 10.2.2 Brand Strategy
        • 10.2.3 Target Client
      • 10.3 Distributors/Traders List

      11 Market Effect Factors Analysis

      • 11.1 Technology Progress/Risk
        • 11.1.1 Substitutes Threat
        • 11.1.2 Technology Progress in Related Industry
      • 11.2 Consumer Needs/Customer Preference Change
      • 11.3 Economic/Political Environmental Change

      12 Global Ophthalmic Therapeutics/Drug Market Forecast (2018-2025)

      • 12.1 Global Ophthalmic Therapeutics/Drug Capacity, Production, Revenue Forecast (2018-2025)
        • 12.1.1 Global Ophthalmic Therapeutics/Drug Capacity, Production and Growth Rate Forecast (2018-2025)
        • 12.1.2 Global Ophthalmic Therapeutics/Drug Revenue and Growth Rate Forecast (2018-2025)
        • 12.1.3 Global Ophthalmic Therapeutics/Drug Price and Trend Forecast (2018-2025)
      • 12.2 Global Ophthalmic Therapeutics/Drug Production, Consumption , Import and Export Forecast by Region (2018-2025)
        • 12.2.1 North America Ophthalmic Therapeutics/Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.2 Europe Ophthalmic Therapeutics/Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.3 China Ophthalmic Therapeutics/Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.4 Japan Ophthalmic Therapeutics/Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.5 Southeast Asia Ophthalmic Therapeutics/Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
        • 12.2.6 India Ophthalmic Therapeutics/Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
      • 12.3 Global Ophthalmic Therapeutics/Drug Production, Revenue and Price Forecast by Type (2018-2025)
      • 12.4 Global Ophthalmic Therapeutics/Drug Consumption Forecast by Application (2018-2025)

      13 Research Findings and Conclusion

        14 Appendix

        • 14.1 Methodology/Research Approach
          • 14.1.1 Research Programs/Design
          • 14.1.2 Market Size Estimation
          • 14.1.3 Market Breakdown and Data Triangulation
        • 14.2 Data Source
          • 14.2.1 Secondary Sources
          • 14.2.2 Primary Sources

        This report studies the global Ophthalmic Therapeutics/Drug market status and forecast, categorizes the global Ophthalmic Therapeutics/Drug market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

        The global Ophthalmic Therapeutics/Drug market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

        The major manufacturers covered in this report
        Alcon
        Johnson and Johnson Vision Care, Inc.
        Bausch & Lomb Incorporated
        Novartis AG
        Merck Sharp & Dohme Corp.
        Regeneron Pharmaceuticals Inc.
        Allergan
        Pfizer Inc.
        Valeant
        Bayer AG
        Santen Pharmaceuticals Co. Ltd
        Genentech, Inc.

        Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        We can also provide the customized separate regional or country-level reports, for the following regions:
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
        Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Argentina
        Rest of South America
        Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

        On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
        Anti-allergy
        Anti-VEGF Agents
        Anti-inflammatory
        Anti-glaucoma
        Others
        On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
        Dry Eye
        Allergies
        Glaucoma
        Infection
        Retinal Disorders
        Uveitis
        Others

        The study objectives of this report are:
        To analyze and study the global Ophthalmic Therapeutics/Drug sales, value, status (2013-2017) and forecast (2018-2025).
        Focuses on the key Ophthalmic Therapeutics/Drug manufacturers, to study the sales, value, market share and development plans in future.
        Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Ophthalmic Therapeutics/Drug are as follows:
        History Year: 2013-2017
        Base Year: 2017
        Estimated Year: 2018
        Forecast Year 2018 to 2025

        For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

        Key Stakeholders
        Ophthalmic Therapeutics/Drug Manufacturers
        Ophthalmic Therapeutics/Drug Distributors/Traders/Wholesalers
        Ophthalmic Therapeutics/Drug Subcomponent Manufacturers
        Industry Association
        Downstream Vendors

        Available Customizations
        With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
        Regional and country-level analysis of the Ophthalmic Therapeutics/Drug market, by end-use.
        Detailed analysis and profiles of additional market players.



        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $2,900.00
        $5,800.00
        2,287.04
        4,574.07
        2,592.81
        5,185.62
        317,808.10
        635,616.20
        201,976.01
        403,952.02
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report